SCOPUS 정보 검색 플랫폼

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 10, 2008, Pages 1129-1134

Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy

(4) Huang, Zhao Hui a,b Hua, Dong a Li, Li Hua a Zhu, Jing De b

a SOOCHOW UNIVERSITY (China)

b FUDAN UNIVERSITY (China)

Author keywords

5 Fluorouracil; Apoptosis; Chemotherapy; Gastric cancer; P53 protein; Polymorphism

Indexed keywords

'TAXON'; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; HYDROXYCAMPTOTHECIN; OXALIPLATIN; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CHINESE; CLINICAL ASSESSMENT; CODON; CONFIDENCE INTERVAL; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; STOMACH CANCER;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASE SEQUENCE; CHEMOTHERAPY, ADJUVANT; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 50249127209 PISSN: 01715216 EISSN: None Source Type: Journal
DOI: 10.1007/s00432-008-0380-8 Document Type: Article

Times cited : (23)

References (34)

1
- 33646946988
- Genetic status of p53 in stomach cancer: Somatic mutations and polymorphism of codon 72
- VA Belyavskaya VK Vardosanidze OY Smirnova EI Karakin IV Savkin PA Gervas NV Cherdyntseva MI Voevoda 2006 Genetic status of p53 in stomach cancer: somatic mutations and polymorphism of codon 72 Bull Exp Biol Med 141 243 246
- (2006) Bull Exp Biol Med , vol.141 , pp. 243-246
- Belyavskaya, V.A.¹ Vardosanidze, V.K.² Smirnova, O.Y.³ Karakin, E.I.⁴ Savkin, I.V.⁵ Gervas, P.A.⁶ Cherdyntseva, N.V.⁷ Voevoda, M.I.⁸

2
- 10744230945
- P53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis
- D Bergamaschi M Gasco L Hiller A Sullivan N Syed G Trigiante I Yulug M Merlano G Numico A Comino M Attard O Reelfs B Gusterson AK Bell V Heath M Tavassoli PJ Farrell P Smith X Lu T Crook 2003 p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis Cancer Cell 3 387 402
- (2003) Cancer Cell , vol.3 , pp. 387-402
- Bergamaschi, D.¹ Gasco, M.² Hiller, L.³ Sullivan, A.⁴ Syed, N.⁵ Trigiante, G.⁶ Yulug, I.⁷ Merlano, M.⁸ Numico, G.⁹ Comino, A.¹⁰ Attard, M.¹¹ Reelfs, O.¹² Gusterson, B.¹³ Bell, A.K.¹⁴ Heath, V.¹⁵ Tavassoli, M.¹⁶ Farrell, P.J.¹⁷ Smith, P.¹⁸ Lu, X.¹⁹ Crook, T.²⁰ more..

3
- 30544452545
- Adjuvant therapy of resected gastric cancer is necessary
- A Carrato J Gallego-Plazas C Guillen-Ponce 2005 Adjuvant therapy of resected gastric cancer is necessary Semin Oncol 32 S105 108
- (2005) Semin Oncol , vol.32 , pp. 105-108
- Carrato, A.¹ Gallego-Plazas, J.² Guillen-Ponce, C.³

4
- 0033832450
- The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil
- RB Diasio MR Johnson 2000 The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil Pharmacology 61 199 203
- (2000) Pharmacology , vol.61 , pp. 199-203
- Diasio, R.B.¹ Johnson, M.R.²

5
- 0037372005
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
- P Dumont JI Leu AC Della Pietra 3rd DL George M Murphy 2003 The codon 72 polymorphic variants of p53 have markedly different apoptotic potential Nat Genet 33 357 365
- (2003) Nat Genet , vol.33 , pp. 357-365
- Dumont, P.¹ Leu, J.I.² Della Pietra III, A.C.³ George, D.L.⁴ Murphy, M.⁵

6
- 33846515743
- Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas
- V Galic J Willner M Wollan R Garg R Garcia BA Goff HJ Gray EM Swisher 2007 Common polymorphisms in TP53 and MDM2 and the relationship to TP53 mutations and clinical outcomes in women with ovarian and peritoneal carcinomas Genes Chromosomes Cancer 46 239 247
- (2007) Genes Chromosomes Cancer , vol.46 , pp. 239-247
- Galic, V.¹ Willner, J.² Wollan, M.³ Garg, R.⁴ Garcia, R.⁵ Goff, B.A.⁶ Gray, H.J.⁷ Swisher, E.M.⁸

7
- 31444431779
- Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)-novel predictors for response and survival in gastric cancer patients
- E Goekkurt S Hoehn C Wolschke C Wittmer C Stueber DK Hossfeld J Stoehlmacher 2006 Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)-novel predictors for response and survival in gastric cancer patients Br J Cancer 94 281 286
- (2006) Br J Cancer , vol.94 , pp. 281-286
- Goekkurt, E.¹ Hoehn, S.² Wolschke, C.³ Wittmer, C.⁴ Stueber, C.⁵ Hossfeld, D.K.⁶ Stoehlmacher, J.⁷

8
- 4043102535
- Treatment of localized gastric cancer
- JS Macdonald 2004 Treatment of localized gastric cancer Semin Oncol 31 566 573
- (2004) Semin Oncol , vol.31 , pp. 566-573
- MacDonald, J.S.¹

9
- 32944473573
- Postoperative chemotherapy for gastric cancer
- M Hejna S Wohrer M Schmidinger M Raderer 2006 Postoperative chemotherapy for gastric cancer Oncologist 11 136 145
- (2006) Oncologist , vol.11 , pp. 136-145
- Hejna, M.¹ Wohrer, S.² Schmidinger, M.³ Raderer, M.⁴

10
- 33748907720
- Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway
- W Ichikawa 2006 Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway Gastric Cancer 9 145 155
- (2006) Gastric Cancer , vol.9 , pp. 145-155
- Ichikawa, W.¹

11
- 0036765664
- Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer
- Y Ishida K Kawakami Y Tanaka E Kanehira K Omura G Watanabe 2002 Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer Anticancer Res 22 2805 2809
- (2002) Anticancer Res , vol.22 , pp. 2805-2809
- Ishida, Y.¹ Kawakami, K.² Tanaka, Y.³ Kanehira, E.⁴ Omura, K.⁵ Watanabe, G.⁶

12
- 0028329172
- Apoptosis. Its significance in cancer and cancer therapy
- JF Kerr CM Winterford BV Harmon 1994 Apoptosis. Its significance in cancer and cancer therapy Cancer 73 2013 2026
- (1994) Cancer , vol.73 , pp. 2013-2026
- Kerr, J.F.¹ Winterford, C.M.² Harmon, B.V.³

13
- 33748517404
- P53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer
- A Koushik GJ Tranah J Ma MJ Stampfer HD Sesso CS Fuchs EL Giovannucci DJ Hunter 2006 p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer Int J Cancer 119 1863 1868
- (2006) Int J Cancer , vol.119 , pp. 1863-1868
- Koushik, A.¹ Tranah, G.J.² Ma, J.³ Stampfer, M.J.⁴ Sesso, H.D.⁵ Fuchs, C.S.⁶ Giovannucci, E.L.⁷ Hunter, D.J.⁸

14
- 20644442259
- Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer
- K Lai W Chen FJ Tsai SY Li LB Jeng 2005 Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer Hepatogastroenterology 52 944 948
- (2005) Hepatogastroenterology , vol.52 , pp. 944-948
- Lai, K.¹ Chen, W.² Tsai, F.J.³ Li, S.Y.⁴ Jeng, L.B.⁵

15
- 0033816806
- Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. a study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente)
- E Mari I Floriani A Tinazzi A Buda M Belfiglio M Valentini S Cascinu S Barni R Labianca V Torri 2000 Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente) Ann Oncol 11 837 843
- (2000) Ann Oncol , vol.11 , pp. 837-843
- Mari, E.¹ Floriani, I.² Tinazzi, A.³ Buda, A.⁴ Belfiglio, M.⁵ Valentini, M.⁶ Cascinu, S.⁷ Barni, S.⁸ Labianca, R.⁹ Torri, V.¹⁰

16
- 0023125537
- Primary structure polymorphism at amino acid residue 72 of human p53
- GJ Matlashewski S Tuck D Pim P Lamb J Schneider LV Crawford 1987 Primary structure polymorphism at amino acid residue 72 of human p53 Mol Cell Biol 7 961 963
- (1987) Mol Cell Biol , vol.7 , pp. 961-963
- Matlashewski, G.J.¹ Tuck, S.² Pim, D.³ Lamb, P.⁴ Schneider, J.⁵ Crawford, L.V.⁶

17
- 34250355147
- Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population
- DD Orsted SE Bojesen A Tybjaerg-Hansen BG Nordestgaard 2007 Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population J Exp Med 204 1295 1301
- (2007) J Exp Med , vol.204 , pp. 1295-1301
- Orsted, D.D.¹ Bojesen, S.E.² Tybjaerg-Hansen, A.³ Nordestgaard, B.G.⁴

18
- 33751569877
- The thymidylate synthase tandem repeat promoter polymorphism: A predictor for tumor-related survival in neoadjuvant treated locally advanced gastric cancer
- K Ott H Vogelsang N Marton K Becker F Lordick M Kobl C Schuhmacher A Novotny J Mueller U Fink K Ulm JR Siewert H Hofler G Keller 2006 The thymidylate synthase tandem repeat promoter polymorphism: A predictor for tumor-related survival in neoadjuvant treated locally advanced gastric cancer Int J Cancer 119 2885 2894
- (2006) Int J Cancer , vol.119 , pp. 2885-2894
- Ott, K.¹ Vogelsang, H.² Marton, N.³ Becker, K.⁴ Lordick, F.⁵ Kobl, M.⁶ Schuhmacher, C.⁷ Novotny, A.⁸ Mueller, J.⁹ Fink, U.¹⁰ Ulm, K.¹¹ Siewert, J.R.¹² Hofler, H.¹³ Keller, G.¹⁴

19
- 33745686040
- Determinants of chemosensitivity in gastric cancer
- DJ Park HJ Lenz 2006 Determinants of chemosensitivity in gastric cancer Curr Opin Pharmacol 6 337 344
- (2006) Curr Opin Pharmacol , vol.6 , pp. 337-344
- Park, D.J.¹ Lenz, H.J.²

20
- 0346121357
- P53 polymorphic variants at codon 72 exert different effects on cell cycle progression
- D Pim L Banks 2004 p53 polymorphic variants at codon 72 exert different effects on cell cycle progression Int J Cancer 108 196 199
- (2004) Int J Cancer , vol.108 , pp. 196-199
- Pim, D.¹ Banks, L.²

21
- 0032511551
- P53 codon 72 polymorphism and risk of cervical cancer in UK
- AN Rosenthal A Ryan RM Al-Jehani A Storey CA Harwood IJ Jacobs 1998 p53 codon 72 polymorphism and risk of cervical cancer in UK Lancet 352 871 872
- (1998) Lancet , vol.352 , pp. 871-872
- Rosenthal, A.N.¹ Ryan, A.² Al-Jehani, R.M.³ Storey, A.⁴ Harwood, C.A.⁵ Jacobs, I.J.⁶

22
- 29244474068
- TP53 and P21 polymorphisms: Response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer
- AM Santos H Sousa C Portela D Pereira D Pinto R Catarino C Rodrigues AP Araujo C Lopes R Medeiros 2006 TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer Biochem Biophys Res Commun 340 256 262
- (2006) Biochem Biophys Res Commun , vol.340 , pp. 256-262
- Santos, A.M.¹ Sousa, H.² Portela, C.³ Pereira, D.⁴ Pinto, D.⁵ Catarino, R.⁶ Rodrigues, C.⁷ Araujo, A.P.⁸ Lopes, C.⁹ Medeiros, R.¹⁰

23
- 16544365295
- P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population
- H Shen A Solari X Wang Z Zhang Y Xu L Wang X Hu J Guo Q Wei 2004 P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population Oncol Rep 11 1115 1120
- (2004) Oncol Rep , vol.11 , pp. 1115-1120
- Shen, H.¹ Solari, A.² Wang, X.³ Zhang, Z.⁴ Xu, Y.⁵ Wang, L.⁶ Hu, X.⁷ Guo, J.⁸ Wei, Q.⁹

24
- 7144250518
- Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
- A Storey M Thomas A Kalita C Harwood D Gardiol F Mantovani J Breuer IM Leigh G Matlashewski L Banks 1998 Role of a p53 polymorphism in the development of human papillomavirus-associated cancer Nature 393 229 234
- (1998) Nature , vol.393 , pp. 229-234
- Storey, A.¹ Thomas, M.² Kalita, A.³ Harwood, C.⁴ Gardiol, D.⁵ Mantovani, F.⁶ Breuer, J.⁷ Leigh, I.M.⁸ Matlashewski, G.⁹ Banks, L.¹⁰

25
- 2442689078
- Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo
- A Sullivan N Syed M Gasco D Bergamaschi G Trigiante M Attard L Hiller PJ Farrell P Smith X Lu T Crook 2004 Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo Oncogene 23 3328 3337
- (2004) Oncogene , vol.23 , pp. 3328-3337
- Sullivan, A.¹ Syed, N.² Gasco, M.³ Bergamaschi, D.⁴ Trigiante, G.⁵ Attard, M.⁶ Hiller, L.⁷ Farrell, P.J.⁸ Smith, P.⁹ Lu, X.¹⁰ Crook, T.¹¹

26
- 0032907105
- Two polymorphic variants of wild-type p53 differ biochemically and biologically
- M Thomas A Kalita S Labrecque D Pim L Banks G Matlashewski 1999 Two polymorphic variants of wild-type p53 differ biochemically and biologically Mol Cell Biol 19 1092 1100
- (1999) Mol Cell Biol , vol.19 , pp. 1092-1100
- Thomas, M.¹ Kalita, A.² Labrecque, S.³ Pim, D.⁴ Banks, L.⁵ Matlashewski, G.⁶

27
- 22344450943
- Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival
- J Tommiska H Eerola M Heinonen L Salonen M Kaare J Tallila A Ristimaki K von Smitten K Aittomaki P Heikkila C Blomqvist H Nevanlinna 2005 Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival Clin Cancer Res 11 5098 5103
- (2005) Clin Cancer Res , vol.11 , pp. 5098-5103
- Tommiska, J.¹ Eerola, H.² Heinonen, M.³ Salonen, L.⁴ Kaare, M.⁵ Tallila, J.⁶ Ristimaki, A.⁷ Von Smitten, K.⁸ Aittomaki, K.⁹ Heikkila, P.¹⁰ Blomqvist, C.¹¹ Nevanlinna, H.¹²

28
- 34548575637
- Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients
- T Toyama Z Zhang M Nishio M Hamaguchi N Kondo H Iwase H Iwata S Takahashi H Yamashita Y Fujii 2007 Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients Breast Cancer Res 9 R34
- (2007) Breast Cancer Res , vol.9 , pp. 34
- Toyama, T.¹ Zhang, Z.² Nishio, M.³ Hamaguchi, M.⁴ Kondo, N.⁵ Iwase, H.⁶ Iwata, H.⁷ Takahashi, S.⁸ Yamashita, H.⁹ Fujii, Y.¹⁰

29
- 0034676455
- Surfing the p53 network
- B Vogelstein D Lane AJ Levine 2000 Surfing the p53 network Nature 408 307 310
- (2000) Nature , vol.408 , pp. 307-310
- Vogelstein, B.¹ Lane, D.² Levine, A.J.³

30
- 0032900988
- P53 codon 72 polymorphism in Taiwanese lung cancer patients: Association with lung cancer susceptibility and prognosis
- YC Wang CY Chen SK Chen YY Chang P Lin 1999 p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis Clin Cancer Res 5 129 134
- (1999) Clin Cancer Res , vol.5 , pp. 129-134
- Wang, Y.C.¹ Chen, C.Y.² Chen, S.K.³ Chang, Y.Y.⁴ Lin, P.⁵

31
- 27144536311
- P53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer
- Y Xu L Yao T Ouyang J Li T Wang Z Fan B Lin Y Lu Y Xie 2005 p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer Clin Cancer Res 11 7328 7333
- (2005) Clin Cancer Res , vol.11 , pp. 7328-7333
- Xu, Y.¹ Yao, L.² Ouyang, T.³ Li, J.⁴ Wang, T.⁵ Fan, Z.⁶ Lin, B.⁷ Lu, Y.⁸ Xie, Y.⁹

32
- 33750967914
- A p53 genetic polymorphism of gastric cancer: Difference between early gastric cancer and advanced gastric cancer
- SY Yi WJ Lee 2006 A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer World J Gastroenterol 12 6536 6539
- (2006) World J Gastroenterol , vol.12 , pp. 6536-6539
- Yi, S.Y.¹ Lee, W.J.²

33
- 0037501107
- Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma
- ZW Zhang P Newcomb A Hollowood R Feakins M Moorghen A Storey MJ Farthing D Alderson J Holly 2003 Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma Clin Cancer Res 9 2151 2156
- (2003) Clin Cancer Res , vol.9 , pp. 2151-2156
- Zhang, Z.W.¹ Newcomb, P.² Hollowood, A.³ Feakins, R.⁴ Moorghen, M.⁵ Storey, A.⁶ Farthing, M.J.⁷ Alderson, D.⁸ Holly, J.⁹

34
- 34548285900
- P53 codon 72 polymorphism and gastric cancer: A meta-analysis of the literature
- Y Zhou N Li W Zhuang GJ Liu TX Wu X Yao L Du ML Wei XT Wu 2007 P53 codon 72 polymorphism and gastric cancer: A meta-analysis of the literature Int J Cancer 121 1481 1486
- (2007) Int J Cancer , vol.121 , pp. 1481-1486
- Zhou, Y.¹ Li, N.² Zhuang, W.³ Liu, G.J.⁴ Wu, T.X.⁵ Yao, X.⁶ Du, L.⁷ Wei, M.L.⁸ Wu, X.T.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.